North Crest Asset Manangement, LLC Tg Therapeutics, Inc. Transaction History
North Crest Asset Manangement, LLC
- $4.13 Billion
- Q4 2025
A detailed history of North Crest Asset Manangement, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 13,991 shares of TGTX stock, worth $433,721. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,991
Previous 13,917
0.53%
Holding current value
$433,721
Previous $502,000
13.75%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding TGTX
# of Institutions
398Shares Held
92.5MCall Options Held
1.77MPut Options Held
1.9M-
Vanguard Group Inc Valley Forge, PA15.8MShares$491 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$353 Million0.0% of portfolio
-
State Street Corp Boston, MA8.1MShares$251 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY4.64MShares$144 Million0.13% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.84MShares$119 Million8.45% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.5B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...